Transcatheter patent ductus arteriosus occlusion: Evolution of techniques and results from the 1990s

Abstract

The Rashkind occluder and the Sideris double-button device both had an unacceptably high rate of residual shunts requiring a second transcatheter procedure or surgical closure. Detachable coils and the Amplatzer ductal occluder have become the current technology of choice for transcatheter PDA closure with high success rates.

A strategic approach to transcatheter closure of patent ductus: Gianturco coils for small-to-moderate ductus and Amplatzer duct occluder for large ductus

“…A second intervention is required when the residual shunt is more than mild or acute hemolysis occurs. In literature, 3-11% patients undergoing coil occlusion required second intervention [21,22]. A multiple coil-no residual shunt strategy may eliminate the need for a second intervention, however, this strategy was applied in patients with a ductus diameter b 4 mm [23].…”

Treatment Options for Pediatric Patent Ductus Arteriosus

“…4 Cardiac catheterization, fi rst used to treat PDAs in 1966, 5 now delivers a variety of devices for PDA occlusion. [6][7][8][9] Few have studied these devices in comparison with surgical ligation. Although preterm infants are too small for the use of transcatheter approaches, controversy remains as to which management option is optimal for the rest of the pediatric population.…”

Atviro arterinio latako perkateterinis uždarymas atsiskiriančiomis COOK spiralėmis – septynerių metų patirtis

“…Liekamojo nuosrûvio rizika padidëja, kai minimalus AAL skersmuo > 2,5 mm, tai leidþia teigti ir tirtø ligoniø duomenys. Daugelis liekamøjø nuosrûviø uþsidaro spon-taniðkai, bet kartais reikia pakartotinai taikyti procedûrà [19]. Pakartotinai spiralës ávestos daþniausiai esant AAL > 2 mm (18,7% atvejø).…”